Aflibercept Plus Folfiri in Asian Patients with Pretreated Metastatic Colorectal Cancer: A Randomized Phase III StudyJin Li, Lin Shen, Rui‐Hua Xu et al.|Future Oncology|2018Cited by 26
A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With DocetaxelPierre Maison‐Blanche, E. Magherini, Sanjiv S. Agarwala et al.|Journal of Cardiovascular Pharmacology|2013Cited by 5